OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic identification of a nuclear receptor-enriched predictive signature for erastin-induced ferroptosis
Ok-Seon Kwon, Eun-Ji Kwon, Hyeon-Joon Kong, et al.
Redox Biology (2020) Vol. 37, pp. 101719-101719
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Transsulfuration, minor player or crucial for cysteine homeostasis in cancer
Haifeng Zhang, Ramon I. Klein Geltink, Seth J. Parker, et al.
Trends in Cell Biology (2022) Vol. 32, Iss. 9, pp. 800-814
Open Access | Times Cited: 89

Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy
Xu Chen, Shiyou Li, Jitang Chen, et al.
Journal of Controlled Release (2023) Vol. 356, pp. 256-271
Closed Access | Times Cited: 41

Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2/GPX4 signal pathway and improving intestinal barrier
Hangping Chen, Yifan Qian, Chensheng Jiang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166984-166984
Open Access | Times Cited: 33

Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma
Qi Tian, Yan Zhou, Lizhe Zhu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 45

Metabolic Regulation of Ferroptosis in Cancer
Min Ji Kim, Greg Jiho Yun, Sung Eun Kim
Biology (2021) Vol. 10, Iss. 2, pp. 83-83
Open Access | Times Cited: 43

MicroRNA-302a-3p induces ferroptosis of non-small cell lung cancer cells via targeting ferroportin
Wei Dong, Yaoqi Ke, Peng Duan, et al.
Free Radical Research (2021) Vol. 55, Iss. 7, pp. 722-731
Closed Access | Times Cited: 42

Comprehensive Analysis of Ferroptosis‐Related Markers for the Clinical and Biological Value in Gastric Cancer
Yanfei Shao, Hongtao Jia, Shuchun Li, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 40

Ferrostatin-1 inhibits osteoclast differentiation and prevents osteoporosis by suppressing lipid peroxidation
Wenbo Xu, Shuai Lv, Xiaoyan Wang, et al.
Journal of Orthopaedic Surgery and Research (2025) Vol. 20, Iss. 1
Open Access

The Protective Role of GPX4 in Naïve ESCs is Highlighted by Induced Ferroptosis Resistance Through GPX4 Expression
Seokwoo Park, Mihn Jeong Park, Eunji Kwon, et al.
Redox Biology (2025) Vol. 81, pp. 103539-103539
Open Access

Overview of Ferroptosis and Synthetic Lethality Strategies
Yuko Kinowaki, Towako Taguchi, Iichiroh Onishi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9271-9271
Open Access | Times Cited: 28

Targeting Ferroptosis for Lung Diseases: Exploring Novel Strategies in Ferroptosis-Associated Mechanisms
Tianliang Ma, Yong Zhou, Ci Wang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 27

Ferroptosis in Lung Cancer: From Molecular Mechanisms to Prognostic and Therapeutic Opportunities
Peyman Tabnak, Zanyar HajiEsmailPoor, Soroush Soraneh
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 27

Systematic omics analysis identifies CCR6 as a therapeutic target to overcome cancer resistance to EGFR inhibitors
Eunji Kwon, Hyuk‐Jin Cha, Haeseung Lee
iScience (2024) Vol. 27, Iss. 4, pp. 109448-109448
Open Access | Times Cited: 4

Engineered nanoplatform mediated gas therapy enhanced ferroptosis for tumor therapy in vivo
Kun Xu, Ke Li, Ye He, et al.
Bioactive Materials (2024) Vol. 44, pp. 488-500
Open Access | Times Cited: 4

Crosstalk between YAP and TGFβ regulates SERPINE1 expression in mesenchymal lung cancer cells
Hyeon‐Joon Kong, Eunji Kwon, Ok‐Seon Kwon, et al.
International Journal of Oncology (2020) Vol. 58, Iss. 1, pp. 111-121
Open Access | Times Cited: 32

A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
Zhi‐Bin Ke, Qi You, Jiang‐Bo Sun, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 17

Remodeling of sorafenib as an orally bioavailable ferroptosis inducer for Lung Cancer by chemical modification of adenine-binding motif
Yun-Jeong Kim, Bumhee Lim, Seo Young Kim, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116758-116758
Open Access | Times Cited: 3

A Novel Ferroptosis-Related Gene Signature Predicts Overall Survival of Breast Cancer Patients
Haifeng Li, Lu Li, Cong Xue, et al.
Biology (2021) Vol. 10, Iss. 2, pp. 151-151
Open Access | Times Cited: 22

Exosomes and ferroptosis: roles in tumour regulation and new cancer therapies
Yixin Shi, Bingrun Qiu, Linyang Huang, et al.
PeerJ (2022) Vol. 10, pp. e13238-e13238
Open Access | Times Cited: 14

Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications
Jie Yu, Qing Wang, Xiaoyun Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13

Ferroptosis as a Potential Cell Death Mechanism against Cisplatin-Resistant Lung Cancer Cell Line
Morteza Golbashirzadeh, Hamid Reza Heidari, Mehdi Talebi, et al.
Advanced Pharmaceutical Bulletin (2021)
Open Access | Times Cited: 11

Prognostic Modeling of Lung Adenocarcinoma Based on Hypoxia and Ferroptosis-Related Genes
Chang Liu, Yan-Qin Ruan, Lai-Hao Qu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-25
Open Access | Times Cited: 7

Development of a ferroptosis-based molecular markers for predicting RFS in prostate cancer patients
Jinquan Chen, Longbin Zhang, Yiling Luo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Evaluation of Erastin as a Therapeutic Agent Under Hypoxic Conditions in Pancreatic Cancer Cells
Satoshi Owada, Hitoshi Endo, Yukari Shida, et al.
Anticancer Research (2021) Vol. 41, Iss. 12, pp. 6051-6059
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top